Similar articles

• Alcohol-associated rapid release of a long-acting opioid.

  Murray S, Wooltorton E. Murray S, et al. CMAJ. 2005 Sep 27;173(7):756. doi: 10.1503/cmaj.051083. Epub 2005 Sep 8. CMAJ. 2005. PMID: 16150957 Free PMC article. No abstract available.
• Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

  Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pergolizzi J, et al. Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
• [Delayed action and rapidly effective in combination. Hydromorphone--already a WHO stage 3 drug].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2006 May 11;148(19):47. MMW Fortschr Med. 2006. PMID: 16736708 German. No abstract available.
• FDA asks Purdue Pharma to withdraw Palladone.

  [No authors listed] [No authors listed] FDA Consum. 2005 Sep-Oct;39(5):7. FDA Consum. 2005. PMID: 16419284 No abstract available.
• Oral hydromorphone extended-release.

  Guay DR. Guay DR. Consult Pharm. 2010 Dec;25(12):816-28. doi: 10.4140/TCP.n.2010.816. Consult Pharm. 2010. PMID: 21172762 Review.